GENESIS Biomed participated in the strategic development of AptaTargets, which has licensed its drug ApTOLL to Merck

by GENESIS Biomed

AptaTargets signed in May 2025 a licensing agreement with Merck for the clinical development and global commercialisation of ApTOLL, an aptamer with neuroprotective effect for the treatment of ischaem...

Read more

Ion Quick: sales de rehidratación oral para una hidratación rápida y eficaz

by Lainco

En Lainco Pharma siguen innovando para cuidar de ti y de los tuyos. Hoy te presentan Ion Quick, su nuevo complemento alimenticio con electrolitos y glucosa, diseñado para una rehidratación oral segu...

Read more

Polymers in Drug Delivery: Shaping the Future of Advanced Therapeutics

by Curapath

Polymers are emerging as powerful alternatives to viral vectors for DNA delivery, enabling safer and more flexible approaches for DNA vaccines and in vivo CAR-T therapies.

Read more

SJD Barcelona has been awarded European MIA accreditation to produce advanced therapies for other centres

by Hospital Sant Joan de Déu

It is the first centre in Spain to achieve this accreditation, which places its operations on a par with those of a pharmaceutical laboratory and consolidates the leadership of the Advanced Therapies ...

Read more
Subscribe to Directory
Write an Article

Recent News

¿Por qué no es recomendable llevar la ...

La mejor actitud que podemos adoptar es la de trat...

Exposure to Heat and Cold During Pregnan...

The research team observed changes in head circumf...

Using mobile RNAs to improve Nitrogen a...

AtCDF3 gene induced greater production of sugars a...

Highlight

Eosinófilos. ¿Qué significa tener val...

by Labo'Life

​En nuestro post hablamos sobre este interesante tipo de célula del...

Researchers Discover How Acute Myeloid L...

by Institut de Recerca Sant Pau

Acute myeloid leukemia (AML) does more than infiltrate the lungs: it a...

Photos Stream